External Thrombosed Hemorrhoid (Acute, <72h)
Investigational adjunct for acute external thrombosed hemorrhoids presenting within 72 hours; distinct from internal hemorrhoidal disease.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for thrombosed external hemorrhoids. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- What evidence exists?
- Tier C (investigational). One small uncontrolled case series describes pain reduction; there are no randomized controlled trials. Evidence-based options within 72 hours of symptom onset include surgical excision under local anesthesia (provides the fastest pain relief and definitive thrombus removal — the highest-evidence option), and conservative management with warm sitz baths, topical analgesics (lidocaine), oral analgesics, fiber, and stool softeners for symptoms peaking and resolving over 7 to 14 days.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment, in a highly vascular and contaminated perianal area
- Local skin infection or, rarely, Aeromonas infection in a high-bacterial-load area
- Allergic reaction to leech saliva (uncommon)
- Severe perianal pain and tenderness for 5 to 10 days
- Worsening of the thrombosed hemorrhoid pain in the first 24 hours
- Damage to anal sphincter if placement is improper (NEVER intra-anal)
- Delay of surgical excision (the fastest pain-relief option within 72 hours)
- Failure to address strangulated or gangrenous hemorrhoids that require emergent surgery
- Who should not consider this
- Patients with strangulated or gangrenous thrombosed hemorrhoid (emergent surgical indication)
- Patients with active perianal abscess or fistula
- Patients with inflammatory bowel disease and active proctitis
- Patients beyond the 72-hour window (natural resolution is beginning)
- Patients on anticoagulants, with hemophilia, or with severe anemia
- Patients with active genital or perianal infection
- Pregnant patients (relative contraindication)
- What to ask your clinician
- Has my external thrombosed hemorrhoid been examined to rule out strangulation, gangrene, or abscess?
- Am I within the 72-hour window where surgical excision provides the fastest relief?
- If conservative, do I have an adequate plan (sitz baths, topical lidocaine, stool softeners, fiber)?
- Where exactly will leeches be placed — on perianal skin, NEVER intra-anal or on the thrombus itself?
- What is the practitioner's experience with perianal anatomy and Aeromonas prevention?
- What is the bleeding-control plan if a perianal site continues to bleed?
- What is my long-term hemorrhoidal-disease prevention plan?
- When to seek urgent care
- Severe worsening perianal pain, fever, or red, hot perianal area (possible abscess — surgical emergency)
- Inability to urinate or defecate after the session
- Bleeding that does not stop with firm pressure or bleeding through padding hourly
- Spreading redness, pus, or red streaks (cellulitis or perirectal infection)
- Fever above 38.0 C / 100.4 F or chills
- Skin discoloration, blackening, or necrosis of the hemorrhoid
- Hives, throat tightness, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for thrombosed external hemorrhoids.
- A single small case series does NOT establish efficacy versus surgical excision within 72 hours.
- Mechanism rationale (local decongestion) does NOT establish clinical equivalence to surgical excision or conservative care.
- Leech therapy is NEVER intra-anal — that placement risk is unacceptable.
- Leech therapy is not a substitute for surgical excision in the 72-hour window or emergent surgery for strangulated / gangrenous hemorrhoids.
Safety cross-references
Clinical Profile
- Category
- gastrointestinal
- ICD-10
- K64.5
- Safety tier
- medium
Evidence Summary
Acute external thrombosed hemorrhoids cause severe perianal pain peaking at 48-72 hours. Surgical excision within 72 hours of onset provides faster pain relief than conservative management (sitz baths, topical analgesics, fiber). No dedicated controlled trial or case series of leech therapy for thrombosed external hemorrhoids has been published; use for this indication is investigational only. If considered at all, leech application would be placed on peripheral perianal skin, never on the thrombus itself and never intra-anally. This is a distinct entity from the registry's grade II-III internal hemorrhoid entry.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Mohsin M et al. (2021), n=14
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Strangulated or gangrenous thrombosed hemorrhoid (emergent surgical)
- Active perianal abscess or fistula
- Inflammatory bowel disease with active proctitis
- Onset >72 hours (natural resolution beginning; risk-benefit unfavorable)
Related Conditions
Hemorrhoids (Grade II-III, Symptomatic)
Investigational use for symptomatic relief of grade II-III internal/external hemorrhoidal disease; does not address anatomic prolapse.
Chronic Anal Fissure (>8 Weeks)
Investigational adjunct for chronic anal fissure refractory to medical therapy; very limited case-report evidence; surgical sphincterotomy remains gold standard.
Non-Alcoholic Fatty Liver Disease (Investigational Adjunct)
Investigational adjunct in NAFLD/MASLD; small case series only; weight loss, dietary modification, and resmetirom remain primary.
Hepatic Portal Congestion (Non-Cirrhotic, Investigational)
Highly investigational adjunct for non-cirrhotic hepatic congestion; case reports only; cirrhosis and portal hypertension are absolute exclusions.